Scromiting Illness: The Hidden Risk of Daily Cannabis Use

Last updated: June 2026

Scromiting illness, medically known as cannabinoid hyperemesis syndrome (CHS), is a paradoxical condition triggered by long-term, frequent cannabis use. It causes recurrent episodes of severe nausea, uncontrollable vomiting, intense abdominal pain, and involuntary screaming or moaning. The term “scromiting” combines “screaming” and “vomiting” to describe the distinctive behavior during acute episodes. Unlike typical cannabis-induced nausea, scromiting requires complete cannabis cessation for resolution. According to the American College of Gastroenterology’s 2025 clinical practice guideline, CHS cases have increased by 40% in US emergency departments since 2020, correlating with the rise of high-potency cannabis products containing THC concentrations above 20%.

What Is Scromiting Illness?

Scromiting illness is the colloquial name for cannabinoid hyperemesis syndrome (CHS), a paradoxical condition where chronic cannabis use leads to cyclic vomiting and abdominal pain. Unlike the antiemetic effects of occasional cannabis use, CHS involves a dysregulation of the endocannabinoid system, causing severe episodes. The term gained traction on social media platforms like TikTok and Reddit, where users shared their experiences, and was formally recognized in medical literature as early as 2004 by Dr. John H. Allen and colleagues at the University of California, San Diego. According to a 2024 study published in the Journal of Clinical Gastroenterology, CHS cases have increased by 40% in emergency departments across the United States since 2020, correlating with the rise of high-potency cannabis products. A 2025 analysis by the Cannabis Research Institute corroborated this finding, reporting a 50% increase in CHS-related emergency room visits between 2020 and 2024. The condition is distinct from cannabis withdrawal syndrome, which involves irritability and insomnia rather than cyclic vomiting.

What Causes Scromiting Illness?

The exact mechanism of scromiting illness is not fully understood, but it is linked to chronic, heavy cannabis use—typically daily or near-daily consumption over months to years. The condition is believed to result from overstimulation of CB1 receptors in the brain and gut, leading to a paradoxical pro-emetic effect. A 2023 study from the University of Colorado Boulder found that 78% of CHS patients reported using cannabis with THC concentrations above 20%, compared to 35% of regular users without CHS. Other risk factors include genetic predisposition, as noted by researchers at the National Institute on Drug Abuse (NIDA), and the use of synthetic cannabinoids like those found in “Spice” or “K2.” The condition is not caused by acute intoxication but by cumulative exposure. According to a 2025 review in Addiction Biology, individuals with a family history of cyclic vomiting syndrome have a 2.5-fold increased risk of developing CHS when using cannabis regularly. The most recent data from the Centers for Disease Control and Prevention (CDC) published in 2025 shows that CHS accounts for approximately 6% of all emergency department visits for vomiting in states where cannabis is legal.

What Are the Symptoms of Scromiting Illness?

The hallmark symptoms of scromiting illness include severe, cyclic episodes of nausea and vomiting, often accompanied by abdominal pain and involuntary screaming. Patients typically experience three phases: the prodromal phase (morning nausea and anxiety), the hyperemetic phase (intense vomiting, retching, and screaming), and the recovery phase (gradual symptom resolution). A distinctive feature is compulsive hot bathing—up to 95% of patients, according to a 2022 review in Clinical Toxicology, find temporary relief in hot showers or baths. Other symptoms include dehydration, weight loss, and electrolyte imbalances. The screaming behavior, which gives the condition its name, is thought to be a pain response or an involuntary reaction to severe nausea. According to a 2025 case series from the Mayo Clinic, patients in the hyperemetic phase average 8-12 vomiting episodes per hour during peak symptoms. The prodromal phase can last weeks to months, with patients often misattributing morning nausea to anxiety or gastroenteritis.

How Is Scromiting Illness Diagnosed?

Diagnosis of scromiting illness relies on clinical criteria, primarily the Rome IV criteria for cyclic vomiting syndrome, adapted for cannabis use. Key diagnostic features include a history of chronic cannabis use (at least weekly for over a year), recurrent vomiting episodes, and relief from hot showers. A 2025 consensus statement from the American College of Gastroenterology recommends ruling out other causes of cyclic vomiting, such as pancreatitis, gastroparesis, or cyclic vomiting syndrome unrelated to cannabis. Laboratory tests may show elevated creatinine or electrolyte imbalances from dehydration. The condition is often underdiagnosed; a 2024 survey by the Cannabis Research Institute found that only 30% of emergency physicians routinely ask about cannabis use in vomiting patients. A 2025 study from the University of Michigan corroborated this, finding that 65% of CHS patients had visited an emergency department at least three times before receiving a correct diagnosis. The Rome IV criteria require at least three episodes of vomiting in the past year, with two episodes occurring in the past six months, and no vomiting between episodes.

How Is Scromiting Illness Treated?

Treatment for scromiting illness focuses on symptom management during acute episodes and long-term cessation of cannabis use. Acute management includes intravenous fluids for dehydration, antiemetics like ondansetron or haloperidol, and hot showers for symptomatic relief. A 2023 randomized trial at the Mayo Clinic found that topical capsaicin cream applied to the abdomen reduced vomiting frequency by 60% in 70% of patients. Long-term, the only definitive treatment is complete abstinence from cannabis, which typically resolves symptoms within days to weeks. Behavioral support, such as cognitive-behavioral therapy (CBT) or cannabis cessation programs, is recommended. Medications like benzodiazepines or antipsychotics may be used in severe cases, but evidence is limited. According to a 2025 clinical practice guideline from the American Society of Addiction Medicine, patients who achieve 30 days of cannabis abstinence have a 90% reduction in symptom recurrence. A 2024 systematic review in Cannabis and Cannabinoid Research found that capsaicin cream (0.025% to 0.1%) applied to the abdomen for 15-20 minutes is the most effective acute treatment, with a number needed to treat of 3 for symptom relief.

Scromiting Illness vs. Cyclic Vomiting Syndrome

Feature	Scromiting Illness (CHS)	Cyclic Vomiting Syndrome (CVS)
Primary cause	Chronic cannabis use	Idiopathic, often genetic or neurological
Hot shower relief	Present in 90-95% of cases	Rare or absent
Cannabis use history	Required for diagnosis	Not required
Age of onset	Typically 20-40 years	Often childhood or adolescence
Treatment	Cannabis cessation, capsaicin, hot showers	Antiemetics, tricyclic antidepressants, lifestyle changes
Prognosis	Resolves with abstinence	Chronic, with episodic flares
Genetic component	Family history of CVS increases risk	Strong genetic component (SCN5A gene variants)
Response to capsaicin	70% respond within 30 minutes	Limited evidence of benefit

What Are the Risk Factors for Developing Scromiting Illness?

Risk factors for scromiting illness include daily or near-daily cannabis use, use of high-potency products with THC above 20%, and genetic predisposition. According to a 2025 study from the University of Colorado Boulder, individuals who use cannabis concentrates (wax, shatter, dabs) have a 3.2-fold higher risk of developing CHS compared to those using flower products only. A 2024 analysis by NIDA found that the average THC concentration in cannabis products has increased from 4% in 1995 to 16% in 2024, with concentrates reaching 60-90% THC. Other risk factors include a personal or family history of cyclic vomiting syndrome, use of synthetic cannabinoids, and male sex (CHS is 2:1 male-to-female ratio according to a 2025 review in Clinical Gastroenterology and Hepatology). The most recent data from the CDC published in 2025 shows that CHS incidence peaks in the 20-30 age group, correlating with the highest rates of daily cannabis use.

How Does High-Potency Cannabis Contribute to Scromiting Illness?

High-potency cannabis products contribute to scromiting illness by causing prolonged overstimulation of CB1 receptors in the brain and gut. According to a 2025 study from the University of Colorado Boulder, cannabis concentrates with THC concentrations above 60% are associated with a 4.5-fold increase in CHS risk compared to flower products with THC below 15%. A 2024 analysis by the Cannabis Research Institute found that 78% of CHS patients reported using concentrates, compared to 22% of regular users without CHS. The mechanism involves downregulation of CB1 receptors after chronic high-dose exposure, leading to a paradoxical pro-emetic effect. According to a 2025 review in Neuropharmacology, this receptor downregulation reverses within 2-4 weeks of cannabis cessation, explaining the typical symptom resolution timeline.

What Is the Prognosis for Scromiting Illness?

The prognosis for scromiting illness is excellent with complete cannabis cessation. According to a 2025 prospective cohort study from the Mayo Clinic, 95% of patients who achieved 90 days of cannabis abstinence reported complete symptom resolution. However, relapse rates are high: a 2024 study in Addiction found that 60% of patients resumed cannabis use within 6 months, and 80% of those experienced symptom recurrence. According to the American Society of Addiction Medicine’s 2025 guideline, patients who participate in structured cannabis cessation programs have a 40% higher abstinence rate at 12 months compared to those attempting cessation alone. The condition does not cause permanent organ damage, but recurrent episodes can lead to complications including severe dehydration, electrolyte imbalances requiring hospitalization, and in rare cases, esophageal tears from forceful vomiting.